Masahiro Nakashima Selected Research

Acetic Acid (Vinegar)

4/2003	IL-11 up-regulates Tie-2 expression during the healing of gastric ulcers in rats.
1/2003	Expression of Tie-2 and angiopoietin-1 and -2 in early phase of ulcer healing.
5/2002	Mechanism of the antiulcerogenic effect of IL-11 on acetic acid-induced gastric ulcer in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Nakashima Research Topics

Disease

58	Neoplasms (Cancer) 08/2023 - 01/2002
21	Carcinogenesis 05/2021 - 01/2002
14	Genomic Instability 01/2021 - 03/2008
13	Thyroid Neoplasms (Thyroid Cancer) 08/2023 - 07/2002
13	Endometriosis 09/2021 - 11/2010
12	Infections 01/2023 - 02/2004
10	Papillary Thyroid Cancer 08/2023 - 07/2002
10	Inflammation (Inflammations) 12/2021 - 01/2006
9	Carcinoma (Carcinomatosis) 12/2022 - 01/2003
8	Adenoma (Adenomas) 07/2022 - 07/2002
6	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2003
6	Adenomyosis 08/2019 - 11/2010
5	Breast Neoplasms (Breast Cancer) 01/2018 - 06/2009
5	Ulcer 06/2014 - 05/2002
4	Rheumatoid Arthritis 01/2022 - 02/2004
4	Bacterial Infections (Bacterial Infection) 10/2021 - 11/2011
4	Stomach Ulcer (Gastric Ulcer) 11/2019 - 05/2002
4	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 10/2003
4	Colitis 06/2014 - 08/2005
4	Anaplastic Thyroid Carcinoma 11/2008 - 01/2003
3	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2017
3	Myoma 04/2019 - 11/2010
3	Proteinuria 01/2018 - 02/2004
3	Hepatitis 01/2013 - 04/2005
2	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 02/2023 - 01/2002
2	Sepsis (Septicemia) 01/2023 - 01/2017
2	Goiter 07/2022 - 03/2021
2	Hemorrhage 03/2022 - 06/2014
2	Albuminuria 01/2022 - 12/2021
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 12/2021
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2002
2	Radiation Injuries (Radiation Sickness) 08/2020 - 02/2005
2	Leiomyosarcoma 11/2019 - 01/2005
2	Melena 11/2019 - 06/2014
2	Pain (Aches) 11/2019 - 01/2013
2	Fibrosis (Cirrhosis) 04/2019 - 04/2004
2	Endometritis 04/2018 - 11/2014
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2017 - 01/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2011 - 05/2005
2	Virus Diseases (Viral Diseases) 09/2011 - 04/2005
2	Esophageal Squamous Cell Carcinoma 03/2011 - 05/2010

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2002
12	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 02/2004
8	Cyclin D1IBA 01/2009 - 01/2002
7	EndotoxinsIBA 04/2018 - 12/2010
7	beta CateninIBA 01/2009 - 01/2002
6	Messenger RNA (mRNA)IBA 01/2022 - 11/2002
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021 - 12/2008
6	LipopolysaccharidesIBA 10/2021 - 12/2012
6	CytokinesIBA 05/2015 - 01/2004
5	Indicators and Reagents (Reagents)IBA 12/2022 - 05/2008
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2019
5	Thyroglobulin FDA Link 01/2020 - 11/2013
4	IodineIBA 12/2021 - 03/2018
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2021 - 11/2010
4	Hormones (Hormone)IBA 04/2018 - 05/2008
4	ParaffinIBA 12/2011 - 07/2002
3	ProstaglandinsIBA 02/2023 - 12/2012
3	C-Reactive ProteinIBA 01/2023 - 08/2013
3	VimentinIBA 01/2020 - 01/2005
3	Toll-Like Receptor 4IBA 04/2018 - 10/2013
3	SteroidsIBA 04/2018 - 08/2013
3	A-factor (Streptomyces)IBA 05/2016 - 04/2004
3	Calbindin 2IBA 11/2015 - 05/2004
3	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2013 - 12/2010
3	MicroRNAs (MicroRNA)IBA 04/2012 - 06/2008
3	Acetic Acid (Vinegar)FDA LinkGeneric 04/2003 - 05/2002
2	Carnitine (L-Carnitine)FDA LinkGeneric 12/2023 - 01/2022
2	theanineIBA 07/2023 - 08/2020
2	Cystine (L-Cystine)IBA 07/2023 - 08/2020
2	Radiation-Sensitizing AgentsIBA 02/2023 - 01/2022
2	Dinoprostone (PGE2)FDA Link 02/2023 - 12/2012
2	Peptides (Polypeptides)IBA 01/2023 - 04/2005
2	Prednisolone (Predate)FDA LinkGeneric 08/2022 - 10/2011
2	GelatinIBA 03/2022 - 10/2019
2	tofacitinibIBA 01/2022 - 01/2021
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 08/2020
2	Abatacept (Orencia)FDA Link 01/2022 - 01/2021
2	ToyocamycinIBA 01/2020 - 01/2017
2	Nonesterified Fatty Acids (NEFA)IBA 01/2020 - 01/2017
2	Cadherins (E-Cadherin)IBA 01/2020 - 02/2015
2	tocilizumab (atlizumab)FDA Link 11/2019 - 11/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 08/2019 - 05/2004
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2019 - 06/2014
2	Estrogens (Estrogen)FDA Link 04/2018 - 08/2013
2	alpha-galactosylceramideIBA 01/2018 - 12/2008
2	Keratins (Keratin)IBA 01/2018 - 11/2015
2	acarboxyprothrombin (PIVKA)IBA 02/2017 - 10/2003
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 04/2015 - 10/2013
2	Carcinoembryonic AntigenIBA 03/2014 - 05/2004
2	OligonucleotidesIBA 09/2013 - 12/2011
2	Transcription Factors (Transcription Factor)IBA 07/2013 - 02/2002

Therapy/Procedure

12	Therapeutics 01/2023 - 04/2003
6	Radiotherapy 02/2023 - 01/2002
2	Injections 10/2021 - 11/2011
2	Nephrectomy 09/2021 - 04/2005
2	Thyroidectomy 08/2021 - 03/2018
2	Hysterectomy 08/2016 - 02/2015
2	Laparotomy 04/2015 - 11/2010